Separation of fluorescently labeled phosphoinositides and sphingolipids by capillary electrophoresis by Wang, Kelong et al.
Separation of fluorescently labeled phosphoinositides and
sphingolipids by capillary electrophoresis
Kelong Wanga, Dechen Jianga,**, Christopher E. Simsa, and Nancy L. Allbrittona,b,*
aDepartment of Chemistry, University of North Carolina, Chapel Hill, NC 27599
bDepartment of Biomedical Engineering, University of North Carolina, Chapel Hill, 27599 and
North Carolina State University, Raleigh, NC 27695
Abstract
Phosphoinositides (PIs) and sphingolipids regulate many aspects of cell behavior and are often
involved in disease processes such as oncogenesis. Capillary electrophoresis with laser induced
fluorescence detection (CE-LIF) is emerging as an important tool for enzymatic assays of the
metabolism of these lipids, particularly in cell-based formats. Previous separations of
phosphoinositide lipids by CE required a complex buffer with polymer additives which had the
disadvantages of high cost and/or short shelf life. Further a simultaneous separation of these
classes of lipids has not been demonstrated in a robust buffer system. In the current work, a simple
separation buffer based on NaH2PO4 and 1-propanol was optimized to separate two sphingolipids
and multiple phosphoinositides by CE. The NaH2PO4 concentration, pH, 1-propanol fraction, and
a surfactant additive to the buffer were individually optimized to achieve simultaneous separation
of the sphingolipids and phosphoinositides. Fluorescein-labeled sphingosine (SFL) and
sphingosine 1-phosphate (S1PFL), fluorescein-labeled phosphatidyl-inositol 4,5-bisphosphate
(PIP2) and phosphatidyl-inositol 3,4,5-trisphosphate (PIP3), and bodipy-fluorescein (BFL)-labeled
PIP2 and PIP3 were separated pairwise and in combination to demonstrate the generalizability of
the method. Theoretical plate numbers achieved were as high as 2×105 in separating fluorophore-
labeled PIP2 and PIP3. Detection limits for the 6 analytes were in the range of 10−18 to 10−20 mol.
The method also showed high reproducibility, as the relative standard deviation of the normalized
migration time for each analyte in the simultaneous separation of all 6 compounds was less than
1%. The separation of a mixture composed of diacylglycerol (DAG) and multiple
phosphoinositides was also demonstrated. As a final test, fluorescent lipid metabolites formed
within cells loaded with BFLPIP2 were separated from a cell lysate as well as a single cell. This
simple and robust separation method for SFL and S1PFL and various metabolites of
phosphoinositide-related signal transduction is expected to enable improved enzymatic assays for
biological and clinical applications.
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Phosphoinositides (PIs) and sphingolipids are important second messenger molecules in
lipid signaling networks. PIs are involved in a broad range of biological functions including
the regulation of cell growth, proliferation, apoptosis and other cellular activities [1,2].
Disordered PI signaling is common to many diseases, including diabetes, cardiovascular
disease, and cancer [3]. For example, the phosphatidylinositol 3-kinase (PI3K) signaling
pathway is involved in cancer cell growth, survival, motility, and metabolism and thus is of
particular relevance as a target for drug development [4]. In this pathway, PI3K converts
PIP2 into PIP3. The phosphatase-and-tensin-homolog-deleted-on-chromosome-ten-(PTEN)
protein plays an important role as a tumor suppressor by catalyzing this reaction in the
reverse direction. Sphingolipids also play critical roles in a variety of biological processes.
Sphingosine-1-phosphate (S1P) is an important second messenger in cell survival and
migration [5–7]. S1P is generated by phosphorylation of sphingosine by sphingosine kinase
1 and 2 (SK1 and SK2). The inhibition of the S1P pathway has proven promising in treating
cancer and autoimmune diseases [8,9]. By virtue of the emerging roles of PI3K and SK1/2,
as important therapeutic targets, direct and validated measurements of the activities of these
lipid-modifying enzymes have become vital topics [2,8,10].
The most common techniques for analyzing phospholipids, including TLC and HPLC, are
time consuming, labor intensive and lack sensitivity and specificity [11,12]. Mass
spectrometry has been useful for lipid analysis, including phosphoinositide profiling [13–
17]; however, mass spectrometry cannot distinguish the regioisomers of the lipids [17].
Moreover, the mass spectra of phospholipid mixtures containing phosphatidylcholine has
been strongly dominated by phosphatidylcholine and lysophosphatidylcholine signals, which
has prevented the detection of other phospholipids even if those lipids were present in
comparable amounts [18]. Lipid signaling has also been analyzed by fluorescence-based
methods. For example, high-throughput assays are based on use of the phosphoinositide-
binding pleckstrin homology (PH) domains as detectors in measuring the production or
localization of PIP3, but such assays typically require very large numbers of cells (105 –
106) [19,20]. GFP-tagged PH domains have been used in microscopy as an indirect assay of
the enzymatic activities of PI3K and PTEN, but these molecularly engineered cell-based
assays have limited applications, particularly for clinical samples [21–23].
In order to overcome these limitations, chemical separation by CE-LIF has emerged as an
effective means for studying a variety of biological analytes including oligonucleotides,
amino acids, proteins and lipid products because of the high separation efficiency and
excellent detection limits. In order to detect the products of lipid metabolic enzymes by
fluorescence-based techniques, a variety of fluorophore-labeled lipid substrates have been
developed, often with similar kinetics to the endogenous substrate [24–29]. Metabolites and
enzyme activities have been monitored by a variety of investigators using CE-LIF applied to
cell lysates and single cells [30–36]. The use of CE in analyzing PI3K and sphingosine
kinase activity for in vitro and cell-based assays has also been demonstrated [24,34,37].
Electrophoresis in a microfluidic device has likewise been applied to phospholipid
separations. Lin et al reported separation of phospholipids in microfluidic-chip-based
micellar electrokinetic chromatography (MEKC) describing a generalized assay format to
monitor the activities of lipid-modifying enzymes by on-chip separation of fluorescently
labeled substrate and product [38]. To demonstrate feasibility, a mixture of the
phosphoinositides phosphatidylinositol (PI), phosphatidylinositol 3-phosphate (PI(3)P) and
phosphatidylinositol 3,4-bisphosphate (PI(3,4)P2) were separated in a buffer incorporating
0.1% of the proprietary Coating-3 reagent (Caliper Life Sciences, Hopkinton, MA) with 20
mM sodium deoxycholate, 35% 1-propanol,100 mM Tris (pH 8.5), 1 mM EDTA, 1 mM
HEPES (pH 7.0), 1 mM MgCl2, 0.2 mM MnCl2, and 0.4% glycerol; however, the PI(3)P
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and PI(3,4)P2 peaks were not completely resolved. Another disadvantage of the separation
buffer was its complex composition. For their assays of SK and PI3K activity using CE-LIF
in a standard glass capillary, the Allbritton group employed a separation buffer containing
the proprietary dynamic coating reagent 5% Eotrol LR (Target Discovery, Palo Alto, CA)
[24,27]. While baseline separation of all analytes was achieved, shortcomings with buffers
utilizing Eotrol included the expense and short shelf life of this reagent. The development of
a simple and robust separation method for sphingosine, S1P, PIP2 and PIP3 labeled with
fluorophores would contribute to the assay of the corresponding enzymes.
The use of fluorescent lipid substrates or reporters coupled with sensitive and high
resolution CE-based analysis has the potential to aid in the unraveling of the complex lipid
metabolic pathways at the single-cell level. The method may make possible the
simultaneous measurement of the activity of multiple lipid metabolizing enzymes, which
would be a boon to lipid signaling pathway investigation. In the current work, a general
method for CE-based lipid separation using a simple and low cost separation buffer was
sought for performing biochemical assays of lipid modifying enzymes. Three pairs of lipids,
sphingosine and S-1P labeled with fluorescein, PIP2 and PIP3 labeled with fluorescein, and
PIP2 and PIP3 labeled with bodipy-fluorescein were used to optimize buffer composition
and separation conditions, and the results were compared with previous methods. In
addition, separation of a mixture composed of DAG and a variety of PIs was evaluated to
test the applicability of this method to a broader range of compounds. Finally separation of
the lipids from a complex biological matrix, a cell lysate or single cell, was assessed.
2. Materials and Methods
2.1 Chemicals and solutions
Sphingosine-fluorescein (SFL), sphingosine 1-phosphate fluorescein (S1PFL, >98%),
Bodipy-fluorescein labeled phosphatidyl-inositol (PI, C6, >98%), phosphatidyl-inositol 4-
phosphate (PI4P, C6, >98%), phosphatidyl-inositol 5-phosphate (PI5P, C6, >98%),
phosphatidyl-inositol 3,4-bisphosphate (PI(3,4)P2, C6, >98%), phosphatidyl-inositol 3,5-
bisphosphate (PI(3,5)P2, C6, >98%), phosphatidyl-inositol 4,5-bisphosphate (BFLPIP2, C6,
>98%) and phosphatidyl-inositol 3,4,5-trisphosphate (BFLPIP3, C6, >98%) were obtained
from Echelon Biosciences Inc. (Salt Lake City, UT, USA). Phosphatidyl-inositol (4,5)-
bisphosphate-fluorescein (PIP2FL, >95%) and phosphatidyl-inositol (3,4,5)-trisphosphate-
fluorescein (PIP3FL, >95%) were from Cayman Chemical (Ann Arbor, MI, USA). Bodipy-
(4,4-difluoro-3a,4a-diaza-s-indacene)-fluorescein (BFL, 99%) was purchased from
Invitrogen (Carlsbad, CA). The Bodipy-fluorescein-diacylglycerol (DAG) was prepared by
converting BFLPIP2 with phospholipase C (PLC). Sodium deoxycholate (SDC, ≥99.0%),
sodium dodecyl sulfate (SDS, ≥98.5%), boric acid (≥99.5%), 1-propanol (≥99.9%) and
magnesium chloride (1.00 M±0.01 M solution) were purchased from Sigma-Aldrich Inc. (St.
Louis, MO, USA). Tris-(hydroxymethyl)aminomethane (Tris, ≥99.8%), 4-(2-
hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES, ≥99.5%), sodium phosphate
monobasic (99.0%) and potassium phosphate monobasic (99.0%) were purchased from
Fisher Scientific (Fair Lawn, NJ, USA).
2.2 Capillary electrophoresis
CE separations were performed using custom-built CE-LIF instruments reported previously
or a commercial instrument [27]. To accomplish separations with the custom-built system, a
potential difference was applied across the fused-silica capillary (Polymicro Technologies,
Phoenix, AZ., ID 50 μm, OD 360 μm, length 41 cm) using a high-voltage power supply
(Spellman CZE1000R, Plainview, NY, USA). The excitation light source was an Argon-ion
laser (488 nm; JDS Uniphase, Santa Rosa, CA, USA) or a diode-pumped solid-state laser
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(473 nm; Lasermate, Pomona, CA, USA) coupled to a single-mode optical fiber (Oz Optics,
Ottawa, Canada). The fluorescence was collected at a right angle to the capillary and the
laser beam using a microscope objective (40x, 0.75 NA, Plan Fluor, Nikon, Melville, NY,
USA), and detected by a photomultiplier tube (PMT, R3896; Hamamatsu, Bridgewater, NJ,
USA) after spectral filtering with a notch filter (473 or 488 nm; Semrock, Lake Forest, IL)
and a band-pass filter (535DF50; Chroma Technology, Rockingham, VT, USA). The PMT
signal was amplified (PMT-5, Advanced Research Instruments, Golden, CO) and collected
by a data acquisition board (KPCI-3100; Keithley Metrabyte, Cleveland, OH, USA or NI
PCI-6229 M, National Instruments Corporation, Austin, TX, USA). The sample was loaded
by hydrodynamic injection and the injection volume was estimated as described previously
[39].
All separations were performed at 22 °C using a voltage of -12 kV at the outlet reservoir
with the inlet reservoir held at ground potential unless otherwise stated. The detection
window on the capillary was created by removing the polyimide coating either 18.1 or 25.3
cm from the inlet. The separation conditions (section 3.1 and 3.2) were optimized using an
automated commercial CE system (ProteomeLab™ PA800; Beckman Coulter, Inc., Brea,
CA) with a standard capillary (ID 50 μm, length 30 cm, detection window at 20 cm). The
separation voltage was 10 kV. Sample loading was performed by pressurizing the inlet (0.5
psi, 5 s) unless otherwise stated.
2.3 Data analysis
The electrophoretic data generated using the custom-built system were plotted and analyzed
using Origin 7.5. The data from the PA800 were processed using the 32 Karat software
(Beckman Coulter, Inc. Brea, CA). Resolution “R” was calculated as: R=2(tm2−tm1)/
(W1+W2) where tm was the migration time and W the peak width. For calculating R of SFL
and S1PFL, the peak width of S1PFL was taken as the combined width of the two isomeric
peaks. The migration time of S1PFL was calculated as the average of the isomeric peaks.
Theoretical plate number N was defined as: N=5.54(tm/W1/2)2 where tm was the migration
time, and W1/2 the peak width at half-height. For S1PFL, N was calculated based on the
peak of the first isomer.
2.4 Separations utilizing biological samples
PC-3 cells were serum-starved for 4.5 h, trypsinized and incubated with BFLPIP2/histone
(200 nM/200 nM) for 5 min at 37 °C. The cells were then washed. The cells were then
suspended in lysis buffer (0.2% triton X-100 and 1 mM Na3VO4 in the electrophoretic
buffer) and frozen in liquid nitrogen until electrophoretically separated. Just prior to
separation BFL (0.1 nM) was added as an internal standard. The lysate sample was
separated using the optimized electrophoretic buffer. In a second assay, serum starved PC-3
cells were loaded with BFLPIP2/histone for 10 min and rinsed with buffer. Single cells were
then loaded into the capillary after laser-based lysis as described previously [32] and the
cellular contents separated in 80% NaH2PO4 (100 mM, pH 7.3) and 1-propanol (20%). The
peaks were identified by comparing the migration time of each with the migration times of
standards and the internal marker BFL (when present).
3. Results and Discussion
3.1 Method development
3.1.1 Choice of separation buffer—The aim of the current work was to develop a
simple, fast, cost-effective and generalizable CE separation method for phospholipid
metabolites. To overcome the disadvantages of previous electrophoretic buffers utilized for
phospholipid separations, we tested a number of separation buffers followed by optimization
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of the most promising one. Since PIP2 was readily obtained with a fluorescein or a bodipy-
fluorescein label, it was desirable to separate the two labeled forms of PIP2 and PIP3.
Additionally, the fluorescent labels impart differing solubility and kinetic parameters for
PI3-K, and thus might be used simultaneously in a single assay [2,40]. The separation of
PIPs and sphingosines in the same sample was performed with the expectation that the
method could be extended to monitor crosstalk between PI3K and sphingosine kinase
signaling pathways in future studies and to further demonstrate the generalizability of the
method for the separation of phospholipid metabolites.
Four buffers were initially screened using the fluorescein-labeled forms of PIP2 and PIP3:
Tris buffer (100 mM, pH = 8.6), boric acid buffer (50 mM, pH = 7.7), Tris-SDC-propanol
(TSP) buffer (100 mM Tris, 10 mM SDC and 15% 1-propanol, pH = 8.5), and NaH2PO4
buffer (40 mM, pH = 5.6). The Tris and boric acid buffers were chosen for initial testing as
they are commonly used CE buffers. The TSP and NaH2PO4 buffers were chosen based on
their prior use for the electrophoretic separation of phospholipids [24,41]. The NaH2PO4
buffer demonstrated the most promise for separating PIP2FL and PIP3FL as this buffer
yielded two sharp and well-separated peaks. The alternative buffers either did not resolve
the two analytes or suffered from poor reproducibility (Figure S1).
3.1.2 Addition of 1-propanol to the NaH2PO4 buffer—Since the NaH2PO4 buffer (40
mM, pH = 5.6) appeared to have potential for the separation of phospholipid analytes, the
buffer was also assessed for its ability to separate SFL and S1PFL. BFL was included as an
internal standard in these separations. The sample was comprised of BFL (0.5 nM), SFL (5
nM) and S1PFL (5 nM) in TSP buffer. The NaH2PO4 buffer alone was unsuitable for
separation of the sphingosines (Figure 1). 1-propanol has been used as an additive for lipid
separations due to its ability to assist in solubilizing the hydrophobic lipids and improve the
separation efficiency of lipid analytes [27]. Different volume fractions of the NaH2PO4
buffer (40 mM, pH = 5.6), 100% -80%, were mixed with varying volume fractions of 1-
propanol (0 – 20%), and this buffer system was assessed for the ability to separate BFL, SFL
and S1PFL. In the presence of 1-propanol between 0 – 10%, BFL, SFL and S1PFL were not
separated (Figure 1). At a concentration of 16% 1-propanol, separation of these three
analytes was achieved. The resolution of SFL and S1PFL was 1.8 ± 0.3 (n = 5). The
resolution of SFL and S1PFL increased to 7.8 ± 1.3 (n = 5) when the 1-propanol
concentration was increased to 20% (Figure 1). The migration times of SFL and S1PFL
were 370 ± 4 s and 493 ± 9 s (n = 5) respectively. The separation of BFL (1nM), PIP2FL (10
nM) and PIP3FL (10 nM) dissolved in a sample matrix of TSP buffer was also performed in
a buffer of 0% and 20% 1-propanol mixed with the NaH2PO4 buffer. With 0% propanol, the
migration time of BFL, PIP2FL and PIP3FL was 236 ± 10, 474 ± 35 and 624 ± 63 s (n = 4),
respectively. The resolution of PIP2FL and PIP3FL was 4.9 ± 1.0. Upon addition of 20% 1-
propanol, the migration times for BFL, PIP2FL and PIP3FL changed to 568 ± 3, 1243 ± 28
and 1623 ± 30 s (n=5) and the resolution of PIP2FL and PIP3FL increased to 6.7 ± 0.6
(n=5). Thus the addition of 20% 1-propanol to the NaH2PO4 buffer (40 mM, pH = 5.6)
enhanced the separation of all of the tested lipid analytes.
3.1.3 Optimization of NaH2PO4 concentration—To further improve the separation of
BFL (0.5 nM), SFL (5 nM) and S1PFL (5 nM) dissolved in TSP buffer matrix, the
NaH2PO4 concentration was optimized. The stock NaH2PO4 buffer pH (pH = 5.6) and v/v
fraction of the stock NaH2PO4 buffer and 1-propanol were kept constant (80/20) while the
concentration of NaH2PO4 stock buffer was varied from 20 to 100 mM, corresponding to a
final NaH2PO4 concentration of 16 to 80 mM, respectively. The concentration of NaH2PO4
influenced the migration time of the analytes as well as their resolution (Figure 2A). The
peak splitting of the SFL and S1PFL was most likely due to the presence of two isomeric
forms of fluorescein as reported in our previous report [24]. At 16 mM NaH2PO4 buffer,
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S1PF and BFL were not resolved. The resolution improved with increasing NaH2PO4 to 6.2
± 1.8 (40 mM, n = 5), 11.4 ± 1.2 (60 mM, n = 4), 11.9 ± 0.8 (80 mM, n = 4) and 12.5 ± 1.2
(100 mM, n = 5). However, the migration times increased from 367 ± 11 s at 32 mM to 513
± 6 s at 80 mM for SFL. Based on these results, NaH2PO4 concentrations of 32, 48 and 64
mM were assessed for the separation of BFL, PIP2FL and PIP3FL (Figure 2B). At 32 mM
NaH2PO4, BFL, PIP2FL and PIP3FL were separated and detected within 28 min, whereas at
48 and 64 mM, not all analytes had eluted after 30 min. For this reason, 32 mM was selected
as the optimal NaH2PO4 concentration.
3.1.4 Assessment of pH—The pH of the stock NaH2PO4 buffer (40 mM, pH 5.6, 7.3, or
8.3) was varied prior to addition of the 1-propanol (20%) and the separation of BFL, PIP2FL
and PIP3FL was assessed (Figure 3A). The migration time, peak height and area, theoretical
plates, and resolution for PIP2FL and PIP3FL are summarized in Table 1. The migration
time of BFL, PIP2FL and PIP3FL decreased with increasing pH from 1490 ± 30 s (n=3) at
pH=5.6 to 1006 ± 23 s (n=5) at pH=8.3 for PIP3FL. The peak height of both PIP2FL and
PIP3FL increased with pH as expected due to the impact of pH on the quantum efficiency of
the flourophore [42]. The peak height of PIP2FL increased 4.5-fold from 0.21 ± 0.01 (n=3)
at pH=5.6 to 0.91 ± 0.04 (n=5) at pH=8.3; the peak height of PIP3FL increased 7-fold from
0.43 ± 0.01(n=3) at pH=5.6 to 2.66 ± 0.11 (n=5) at pH=8.3. The theoretical plates for
PIP2FL and PIP3FL also improved as pH increased. Theoretical plates for PIP2FL rose 2.5-
fold from 4.7×104 ± 2.2×103 (n=3) at pH=5.6 to 1.2×105 ± 3.4×103 (n=5) at pH=8.3, and for
PIP3FL rose 3-fold from 4.43×104 ± 2.6×103 (n=3) at pH=5.6 to 1.2×105 ± 2.2×103 (n=5) at
pH=8.3. The resolution at pH 5.6 was 5.4 ± 0.1 (n=3), but decreased as the pH increased to
2.9 ± 0.1 (n=5) at pH 7.3 and 1.3 ± 0.1 (n=5) at pH 8.3. For the separation of PIP2FL and
PIP3FL, a pH of 7.3 for the NaH2PO4 buffer with 1-propanol provided the best compromise
between resolution and analyte fluorescence intensity.
The separation of SFL (5 nM) and S1PFL (5 nM) in TSP buffer matrix was also performed
in the NaH2PO4-propanol buffer system at varying pH (Figure 3B). BFL, SFL and S1PFL
were separated within 12 minutes at all three pH values. The migration time, peak height,
theoretical plates and resolution are summarized in Table S1. The migration time of BFL
decreased with increasing pH so that the peak elution sequence was dependent on pH. At pH
5.3, the migration velocity of SFL and S1PFL was greater than BFL, but above this pH the
neutral BFL migrated between the sphingosine analytes. As with the PIP2FL and PIP3FL
separation, the peak intensities of SFL and S1PFL increased with the pH of the buffer.
Again, peak splitting of the S1PFL due to the two fluorescein isomers was seen [24]. The
peak height of SFL increased from 0.1 ± 0.01 at pH=5.6 to 0.4 ± 0.1 at pH=7.3 and 2.5 ± 0.5
at pH=8.3 (n=5). The sharp increase in the SFL signal from pH 7.3 to 8.3 seen in the figure
may be due to stacking as the sample is in a high pH buffer (pH=8.5) while the separation
buffer pH is lower [43]. Of the three buffer pH conditions, the pH 8.3 NaH2PO4 buffer
(80%) with 1-propanol (20%) possessed the best performance with regards to analyte signal
intensity and resolution for the sphingosine analytes.
3.1.5 Sample matrix comparison—Prior work demonstrated that efficient dissolution
of PIP2 and PIP3 in the sample matrix was an important factor in achieving high separation
efficiency and resolution by CE [27]. Thus, the sample matrix for the phospholipid
preparation was also optimized in this work. Four sample solvents were tested: TSP buffer
(100 mM Tris, 10 mM SDC and 15% 1-propanol, pH = 8.5), the NaH2PO4 electrophoresis
buffer (32 mM NaH2PO4, pH = 7.3, 20% of 1-propanol), extracellular buffer (ECB, 135
mM NaCl, 5 mM KCl, 10 mM HEPES, 2 mM MgCl2, and 2 mM CaCl2, pH = 7.4), and PBS
buffer (137 mM NaCl, 27 mM KCl, 10 mM NaH2PO4, 1.75 mM KH2PO4, pH = 7.4). TSP
buffer was tested since SDC is often used to disperse lipids [24,27]. ECB and PBS buffers
were chosen as these buffers are cell compatible and are often used as the sample matrix
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when cells or lysates are separated by CE [29,34]. BFL (1 nM), PIP2FL (10 nM) and
PIP3FL (10 nM) were dissolved in each of the sample matrices and then separated in the
buffer system optimized for the phosphoinositide analytes (NaH2PO4 32 mM, pH 7.3 and
20% 1-propanol). When the analytes were dissolved in ECB and PBS, the migration times,
resolution and theoretical plates of the analytes were not reproducible (data not shown).
Table S2 summarizes the separation results when TSP or the electrophoresis buffer was used
as the sample matrix. TSP buffer was selected as the best sample matrix since it yielded less
variation in the analyte migration times and peak areas relative to that of the other buffers.
3.2 Separation of lipids under optimized conditions
3.2.1 Separation of PIP2FL and PIP3FL—A mixture of PIP2FL and PIP3FL (1 nM of
each analyte in TSP) was separated in the optimal buffer. The two peaks were well separated
in 19 min. (Figure 4A) with R = 1.8 ± 0.1 (n=3) and N = 1.8×105 ± 9×102 for PIP2FL and N
= 1.8×105 ± 2×103 for PIP3FL. The migration times of PIP2FL and PIP3FL were highly
reproducible at 1062 ± 4 s (PIP2FL) and 1111 ± 4 s (PIP3FL) (Table 2). The limit of
detection (LOD) was 3×10−20 mol for PIP2FL and 2×10−20 mol for PIP3FL at an S/N of 3.0
(n = 5).
3.2.2 Separation of BFLPIP2 and BFLPIP3—A mixture of BFLPIP2 and BFLPIP3 (1
nM of each analyte in TSP) was separated in the optimal buffer (Figure 4B) with R=3.7 ±
0.1 (n=3). The migration times of BFLPIP2 and BFLPIP3 were 779 ± 5 and 834 ± 6 s (n =
3) with theoretical plates of 2.1×105 ± 4×103 and 2.0×105 ± 3×103, respectively (Table 2).
The LODs of BFLPIP2 and BFLPIP3 were 4×10−20 and 2×10−20 mol at an average S/N of 3
(n = 5). The separation efficiency was improved in comparison to our prior results for these
analytes [27]. Likewise, the theoretical plates improved by 54%. These data clearly
demonstrate improvements over prior methods that required a complex buffer and high-cost
reagents [38].
3.2.3 Separation of SFL and S1PFL—Separation of BFL (0.5 nM), SFL (10 nM), and
S1PFL (10 nM) dissolved in TSP matrix was performed in the optimal buffer, since a buffer
was sought for simultaneous separation of all of the lipid species (Figure 4C). The
separation of SFL and S1PFL was completed in 11 min with a theoretical plate number and
migration time for SFL of 5.2×104 ± 4×103 and 461± 4 s. The peak splitting due to the two
isomeric forms was again observed for S1PFL [24]. For this separation, N=2.7×105 ±
2.5×104 for S1PFL (n = 5), and R was 12.6 ± 0.6. Despite using a simpler buffer system, the
resolution for this lipids separation was improved relative to that reported by the Allbritton
lab previously [24]. The LOD for SFL was 4×10−19 mol and S1PFL was 3×10−19 mol with
corresponding S/N of 3. Again, these results demonstrate improved detection limits and
separation efficiency for these fluorescently labeled sphingosines over prior reports [24,37].
3.3 Separation of mixtures of lipids
The goal of this work was to simultaneously measure multiple lipid metabolites from a
biological sample. Thus a mixture of six lipids, including SFL (10.0 nM), S1PFL (2.0 nM),
BFLPIP2 (1.0 nM), BFLPIP3 (2.0 nM), PIP2FL (0.5 nM) and PIP3FL (1.5 nM), was
separated using the optimal buffer and sample solvent conditions (Figure 5A). BFL (1.0 nM)
was also included as an internal standard. The migration times, peak heights and peak areas
for this separation are listed in Table 3. The reproducibility of the migration time, peak
height, and peak area was excellent for each analyte. These data show successful and
reproducible separation of the six lipid analytes plus an internal standard using a simple
buffer system.
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Phosphoinsotide metabolism is carried out by a complex network of enzymes that can act on
a single substrate to create multiple products. For example, PI(4,5)P2 can be converted into:
PIP3 by PI3K, to PI4P or PI5P by phosphatases, or to DAG by phospholipase C (PLC).
These metabolites can then be converted to additional products, for example, PIP3 can be
metabolized to PI(4,5)P2 or PI(3,4)P2 by the phosphatases PTEN and SHIP, respectively
[44–46]. In order to determine whether the current buffer would be able to separate these
different lipid metabolites simultaneously, a mixture composed of BFL (0.04 nM), and BFL-
labeled DAG (4.7 nM), PI (0.04nM), PI4P (0.2 nM), PI5P (0.4 nM), PI(3,4)P2 (0.4 nM),
PIP2 (0.4 nM), PI(3,5)P2 (0.4 nM) and PIP3 (0.4 nM) was separated (Figure 5B). All
analytes were baseline separated (Table S3) except for two sets of lipid pairs which differed
only in the phosphate location on the inositol ring: PI4P/PI5P, and PI(3,4)P2/PIP2. Two
additional peaks were identified and were due to impurities present in the standard
compounds. Efficient separations such as these of multiple lipid metabolites will be valuable
in parallel monitoring of the lipid signaling enzymes in cells.
3.4 Separation of lipid mixtures from cell lysates and single cells
PC-3 cells, a prostate carcinoma cell line with upregulated PI3K activity, were loaded with
BFLPIP2 by incubation with BFLPIP2 complexed to histone and washed as described
previously [34]. The cells were then lysed and the lysate separated electrophoretically using
the optimized buffer conditions (Figure 6A). A variety of fluorescent metabolites were
formed in the cell from the starting material, BFLPIP2. Formation of BFLPIP3 by PI3K was
readily detected as was formation of BFL-DAG from the action of phospholipase C. BFL-PI
was also present as was two unknown fluorescent metabolites. As a greater challenge, a
single PC-3 cell was loaded with BFLPIP2, washed, and the contents of a single cell loaded
into the capillary and electrophoresed (n = 2 cells). A similar set of metabolites were present
in the single cells although in different relative amounts (Figure 6B). Thus, separation and
detection of lipid metabolites in a cell lysate or a single cell was readily performed with this
method. The two unidentified metabolite peaks seen in the electropherogram demonstrate a
limitation in the use of fluorescently tagged exogenous lipids for these assays. To identify
these peaks, electrophoretic standards are needed. These can be generated by a priori
synthesis of expected metabolic products, or the use of an analytical method such as mass
spectrometry coupled to CE-LIF.
4. Conclusion
A simple buffer system was developed to achieve reproducible separation of a variety of
phospholipids at room temperature. The optimized method incorporated a buffer composed
of 32 mM NaH2PO4, pH=7.3, 20% 1-propanol in a bare capillary. The method provided
improved reproducibility and reduced reagent cost compared with separation matrices
described in prior reports. In separating PIP2FL and PIP3FL, this new CE separation method
provided 54% higher theoretical plate numbers than previous methods. Separations of six
fluorescently labeled phospholipids were conducted using this method. The RSD of the
migration time for all six phospholipids was less than 1%. In future experiments, this
method should enable the separation of fluorescently labeled lipids and their metabolites
from complex biological samples. As demonstrated, the fluorescent substrates can be loaded
into cells followed by separation of the cellular contents and any fluorescent metabolites
formed to better understand cellular metabolism of lipids. The approach is expected to be of
value in the assay of phosphoinositides in drug discovery and in small biological samples
such as single cells.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Capillary electrophoresis was used to separate phosphoinositides and sphingolipids.
A separation buffer based on NaH2PO4 and 1-propanol was optimized.
Theoretical plate numbers were up to 2×105 for the lipids.
Detection limits for the six lipid analytes was between 10−18 to 10−20 mol.
Lipid metabolites from single cells were detected.
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Separation of BFL, SFL and S1PFL in a buffer composed of different volume fractions of
NaH2PO4 (40 mM, pH = 5.6) mixed with 1-propanol. Curves from the top to the bottom
were generated using three different separation buffers: NaH2PO4 buffer (40 mM, pH =
5.6)- top trace, 84% (v/v) of NaH2PO4 buffer (40 mM, pH = 5.6) with 16% 1-propanol-
middle trace, and 80% (v/v) of NaH2PO4 buffer (40 mM, pH = 5.6) with 20% 1-propanol-
lower trace. The corresponding offsets of the y axis are 0.8, 0.4 and 0 for the top, middle and
lower traces, respectively.
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Impact of NaH2PO4 concentration. (A) Separation of BFL, SFL andS1PFL with 16, 32, 48,
and 80 mM NaH2PO4 (pH = 5.6) buffer with 20% 1-propanol (from top to bottom). (B)
Separation of PIP2FL and PIP3FL with NaH2PO4 buffer (pH = 5.6, 20% 1-propanol) at
different concentrations: 32, 48 and 64 (from top to bottom). The corresponding offsets of y
axis are 1.0, 0.5 and 0, respectively. The “1” marks an impurity in the stock S1PFL.
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Influence of pH. (A) Separation of PIP2FL and PIP3FL with NaH2PO4 buffer (32 mM
NaH2PO4, 20% 1-propanol) at pH 5.6, 7.3 and 8.3 (from top to bottom). (B) Separation of
SFL and S1PFL with NaH2PO4 buffer (80% (v/v) of 40mM NaH2PO4, 20% 1-propanol) at
pH 5.6, 7.3 and 8.3 (from top to bottom).
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Separation of lipids in the optimal buffer and sample matrix. (A) Separation of PIP2FL and
PIP3FL. (B) Separation of BFLPIP2 and BFLPIP3. (C) Separation of BFL, SFL and S1PFL.
In (A) and (B), peaks 1 and 2 were impurities in the lipid stocks.
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Simultaneous separation of multiple lipids. (A) Separation of six lipids. A mixture of BFL,
SFL, S1PFL, PIP2FL, PIP3FL, BFLPIP2 and BFLPIP3 was separated with the optimal
buffer. Peaks numbered 1, 2, 3 and 4 are impurities from the commercial SFL and S1PFL
stocks. (B) Separation of a mixture composed of BFL, BFL-labeled DAG, PI, PI4P, PI5P,
PI(3,4)P2, PIP2, PI(3,5)P2 and PIP3. Peaks numbered 1 and 2 are impurities in the supplied
phosphoinositides.
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Separation of lipids from a biological matrix. Separation of fluorescent lipid metabolites
from a cell lysate (A) or from a single cell (B). Peaks 1 and 2 are unknown fluorescent
metabolites. Peak 3 is an endogenous cell component with fluorescence.
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